{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:12:04Z","timestamp":1792267924865,"version":"4.4.0"},"reference-count":191,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","id.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.idc.2015.10.006","type":"journal-article","created":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T15:29:26Z","timestamp":1455809366000},"page":"179-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":637,"title":["Cryptococcosis"],"prefix":"10.1016","volume":"30","author":[{"given":"Eileen K.","family":"Maziarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Perfect","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2015.10.006_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1439-0507.1994.tb00418.x","article-title":"One hundred years ago: the history of cryptococcosis in Greifswald. Medical mycology in the nineteenth century","volume":"37","author":"Knoke","year":"1994","journal-title":"Mycoses"},{"key":"10.1016\/j.idc.2015.10.006_bib2","series-title":"Cryptococcus neoformans","author":"Casadevall","year":"1998"},{"key":"10.1016\/j.idc.2015.10.006_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.idc.2015.10.006_bib4","doi-asserted-by":"crossref","first-page":"17258","DOI":"10.1073\/pnas.0402981101","article-title":"A\u00a0rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)","volume":"101","author":"Kidd","year":"2004","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.idc.2015.10.006_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3201\/eid1702.101020","article-title":"Risk factors for Cryptococcus gattii infection, British Columbia, Canada","volume":"17","author":"MacDougall","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2015.10.006_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/cid\/cir756","article-title":"Cryptococcus gattii Infection in healthy Hosts: A Sentinel for Subclinical Immunodeficiency?","volume":"54","author":"Marr","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib7","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis","volume":"190","author":"Rosen","year":"2013","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.idc.2015.10.006_bib8","doi-asserted-by":"crossref","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"MBio"},{"key":"10.1016\/j.idc.2015.10.006_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/clinids\/20.3.611","article-title":"Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome","volume":"20","author":"Mitchell","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib10","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/cid\/cir723","article-title":"Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen","volume":"53","author":"Harris","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2015.10.006_bib11","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/CMR.00126-13","article-title":"Cryptococcus gattii infections","volume":"27","author":"Chen","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1016\/j.idc.2015.10.006_bib12","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/cid\/civ041","article-title":"Longitudinal clinical findings and outcome among patients with Cryptococcus gattii infection in British Columbia","volume":"60","author":"Phillips","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fgb.2015.02.009","article-title":"Recognition of seven species in the Cryptococcus gatti\/Cryptococcus neoformans species complex","volume":"78","author":"Hagen","year":"2015","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.idc.2015.10.006_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/313992","article-title":"Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group","volume":"31","author":"Chen","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.idc.2015.10.006_bib15","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1111\/mec.13260","article-title":"Comparative analyses of clinical and environmental populations of Cryptococcus neoformans in Botswana","volume":"24","author":"Chen","year":"2015","journal-title":"Mol Ecol"},{"issue":"3","key":"10.1016\/j.idc.2015.10.006_bib16","first-page":"227","article-title":"Saprophytic sources of Cryptococcus neoformans associated with the pigeon (Columba livia)","volume":"62","author":"Emmons","year":"1955","journal-title":"Am J Hyg"},{"key":"10.1016\/j.idc.2015.10.006_bib17","doi-asserted-by":"crossref","first-page":"15245","DOI":"10.1073\/pnas.261418798","article-title":"Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages","volume":"98","author":"Steenbergen","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"1","key":"10.1016\/j.idc.2015.10.006_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/00362178285380051","article-title":"Control of Cryptococcus neoformans in nature by biotic factors","volume":"20","author":"Ruiz","year":"1982","journal-title":"Sabouraudia"},{"key":"10.1016\/j.idc.2015.10.006_bib19","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1128\/JCM.28.7.1642-1644.1990","article-title":"Natural habitat of Cryptococcus neoformans var gattii","volume":"28","author":"Ellis","year":"1990","journal-title":"J\u00a0Clin Microbiol"},{"issue":"Pt 9","key":"10.1016\/j.idc.2015.10.006_bib20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1099\/jmm.0.05427-0","article-title":"Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): epidemiology, microbiology and histopathology","volume":"53","author":"Hoang","year":"2004","journal-title":"J\u00a0Med Microbiol"},{"issue":"8","key":"10.1016\/j.idc.2015.10.006_bib21","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3201\/eid1508.081384","article-title":"Spread of Cryptococcus gattii into Pacific Northwest region of the United States","volume":"15","author":"Datta","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2015.10.006_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3201\/eid1601.090369","article-title":"Projecting global occurrence of Cryptococcus gattii","volume":"16","author":"Springer","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.genet.36.052402.152652","article-title":"Genetics of Cryptococcus neoformans","volume":"36","author":"Hull","year":"2002","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.idc.2015.10.006_bib24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nature03448","article-title":"Sexual reproduction between partners of the same mating type in Cryptococcus neoformans","volume":"434","author":"Lin","year":"2005","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.idc.2015.10.006_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/02681219880000661","article-title":"Pathogenicity of basidiospores of Filobasidiella neoformans var. neoformans","volume":"36","author":"Sukroongreung","year":"1998","journal-title":"Med Mycol"},{"key":"10.1016\/j.idc.2015.10.006_bib26","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/nature04220","article-title":"Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak","volume":"437","author":"Fraser","year":"2005","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.idc.2015.10.006_bib27","doi-asserted-by":"crossref","first-page":"e1000850","DOI":"10.1371\/journal.ppat.1000850","article-title":"Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the Northwest United States","volume":"6","author":"Byrnes","year":"2010","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.idc.2015.10.006_bib28","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/EC.2.6.1162-1168.2003","article-title":"Evidence of sexual recombination among Cryptococcus neoformans serotype A isolates in sub-Saharan Africa","volume":"2","author":"Litvintseva","year":"2003","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.idc.2015.10.006_bib29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1086\/314606","article-title":"Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group","volume":"179","author":"Hajjeh","year":"1999","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0891-5520(02)00036-3","article-title":"Cryptococcosis","volume":"16","author":"Perfect","year":"2002","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.idc.2015.10.006_bib31","series-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","first-page":"2934","article-title":"Cryptococcus neoformans and Cryptococcus gattii","author":"Perfect","year":"2015"},{"issue":"8","key":"10.1016\/j.idc.2015.10.006_bib32","doi-asserted-by":"crossref","first-page":"e43582","DOI":"10.1371\/journal.pone.0043582","article-title":"Comparison and temporal trends of three groups with Cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative\/non-transplant","volume":"7","author":"Bratton","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.idc.2015.10.006_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/1369378031000137224","article-title":"Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts","volume":"41","author":"Christianson","year":"2003","journal-title":"Med Mycol"},{"issue":"5","key":"10.1016\/j.idc.2015.10.006_bib34","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1542\/peds.107.5.e66","volume":"107","author":"Goldman","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.idc.2015.10.006_bib35","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.4049\/jimmunol.175.5.3244","article-title":"An innate immune system cell is a major determinant in species-related susceptibility to fungal pneumonia","volume":"175","author":"Shao","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.idc.2015.10.006_bib36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.femsim.2005.06.005","article-title":"Cryptococcus neoformans: a sugar-coated killer with designer genes","volume":"45","author":"Perfect","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"9","key":"10.1016\/j.idc.2015.10.006_bib37","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/656584","article-title":"Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients","volume":"51","author":"Sun","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2015.10.006_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11046-010-9328-z","article-title":"Pathogenesis of pulmonary Cryptococcus gattii infection: a rat model","volume":"170","author":"Krockenberger","year":"2010","journal-title":"Mycopathologia"},{"key":"10.1016\/j.idc.2015.10.006_bib39","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1128\/IAI.72.4.2229-2239.2004","article-title":"Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model","volume":"72","author":"Santangelo","year":"2004","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.idc.2015.10.006_bib40","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1111\/j.1462-5822.2012.01819.x","article-title":"Cryptococcus neoformans phospholipase B1 activates host cell Rac1 for traversal across the blood-brain barrier","volume":"14","author":"Maruvada","year":"2012","journal-title":"Cell Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2015.10.006_bib41","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1172\/JCI41963","article-title":"Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain","volume":"120","author":"Ahi","year":"2010","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.idc.2015.10.006_bib42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1128\/IAI.01065-08","article-title":"Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans","volume":"77","author":"Charlier","year":"2009","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.idc.2015.10.006_bib43","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1172\/JCI42949","article-title":"Cryptococci at the brain gate: break and enter or use a Trojan horse?","volume":"120","author":"Casadevall","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.idc.2015.10.006_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800261-2.00001-3","article-title":"The tools for virulence of Cryptococcus neoformans","volume":"87","author":"Coelho","year":"2014","journal-title":"Adv Appl Microbiol"},{"key":"10.1016\/j.idc.2015.10.006_bib45","doi-asserted-by":"crossref","first-page":"e1000953","DOI":"10.1371\/journal.ppat.1000953","article-title":"Cryptococcal cell morphology affects host cell interactions and pathogenicity","volume":"6","author":"Okagaki","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.idc.2015.10.006_bib46","doi-asserted-by":"crossref","first-page":"e1000945","DOI":"10.1371\/journal.ppat.1000945","article-title":"Fungal cell gigantism during mammalian infection","volume":"6","author":"Zaragoza","year":"2010","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.idc.2015.10.006_bib47","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1073\/pnas.052702799","article-title":"Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm","volume":"99","author":"Tucker","year":"2002","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.idc.2015.10.006_bib48","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.cub.2006.09.061","article-title":"Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages","volume":"16","author":"Alvarez","year":"2006","journal-title":"Curr Biol"},{"issue":"7","key":"10.1016\/j.idc.2015.10.006_bib49","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1128\/IAI.05613-11","article-title":"Surfactant protein D facilitates Cryptococcus neoformans infection","volume":"80","author":"Geunes-Boyer","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.idc.2015.10.006_bib50","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.7326\/0003-4819-69-6-1109","article-title":"The spectrum of pulmonary cryptococcosis","volume":"69","author":"Warr","year":"1968","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.idc.2015.10.006_bib51","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0031-1295720","article-title":"Pulmonary cryptococcosis","volume":"32","author":"Brizendine","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.idc.2015.10.006_bib52","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cit341","article-title":"Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus Gattii","volume":"57","author":"Chen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib53","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1473-3099(14)70945-4","article-title":"Management of Cryptococcus gattii meningoencephalitis","volume":"15","author":"Franco-Paredes","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/clinids\/21.1.28","article-title":"Clinical and host differences between infections with the two varieties of Cryptococcus neoformans","volume":"21","author":"Speed","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib55","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1399-0012.1997.tb00783.x","article-title":"Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus","volume":"11","author":"Singh","year":"1997","journal-title":"Clin Transplant"},{"key":"10.1016\/j.idc.2015.10.006_bib56","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/emboj\/16.10.2576","article-title":"Calcineurin is required for virulence of Crytptococcus neoformans","volume":"16","author":"Odom","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.idc.2015.10.006_bib57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1445-5994.1982.tb03816.x","article-title":"Disseminated cryptococcosis after transurethral resection of the prostate","volume":"12","author":"Allen","year":"1982","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.idc.2015.10.006_bib58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/0003-4819-111-2-125","article-title":"Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group","volume":"111","author":"Larsen","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2015.10.006_bib59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/myc.1990.33.7-8.369","article-title":"Persistence of Cryptococcus neoformans in seminal fluid and urine under itraconazole treatment. The urogenital tract (prostate) as a niche for Cryptococcus neoformans","volume":"33","author":"Staib","year":"1990","journal-title":"Mycoses"},{"key":"10.1016\/j.idc.2015.10.006_bib60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/archopht.1964.00970010068009","article-title":"Ophthalmologic complications of cryptococcal meningitis","volume":"71","author":"Okun","year":"1964","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.idc.2015.10.006_bib61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00005792-199307000-00001","article-title":"Catastrophic visual loss due to Cryptococcus neoformans meningitis","volume":"72","author":"Rex","year":"1993","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.idc.2015.10.006_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0732-8893(97)00190-9","article-title":"Cryptococcal osteomyelitis: case report and review","volume":"30","author":"Liu","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib63","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s15010-005-4120-6","article-title":"Cryptococcus neoformans peritonitis in a patient with alcoholic cirrhosis: case report and review of the literature","volume":"33","author":"Albert-Braun","year":"2005","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.idc.2015.10.006_bib64","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome during HAART","volume":"19","author":"Shelburne","year":"2005","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.idc.2015.10.006_bib65","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/01.aids.0000174450.70874.30","article-title":"Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France","volume":"19","author":"Lortholary","year":"2005","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.idc.2015.10.006_bib66","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/QAI.0b013e3181a56f2e","article-title":"Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study","volume":"51","author":"Bicanic","year":"2009","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.idc.2015.10.006_bib67","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1086\/605497","article-title":"Cryptococcal immune reconstitution inflammatory syndrome after HAART in AIDS patients with cryptococcal meningitis: a prospective multicenter study","volume":"49","author":"Sungkanuparph","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2015.10.006_bib68","doi-asserted-by":"crossref","first-page":"e1000384","DOI":"10.1371\/journal.pmed.1000384","article-title":"Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study","volume":"7","author":"Boulware","year":"2010","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.idc.2015.10.006_bib69","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/630208","article-title":"Defining immune reconstitution inflammatory syndrome: evaluation of expert opinion versus 2 case definitions in a South African cohort","volume":"49","author":"Haddow","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2015.10.006_bib70","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/428618","article-title":"The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of HAART","volume":"40","author":"Shelburne","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2015.10.006_bib71","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/QAI.0b013e318061b5eb","article-title":"Timing of cryptococcal immune reconstitution inflammatory syndrome after HAART in patients with AIDS and cryptococcal meningitis","volume":"45","author":"Sungkanuparph","year":"2007","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"11","key":"10.1016\/j.idc.2015.10.006_bib72","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/587667","article-title":"Outcomes of cryptococcal meningitis in Uganda before and after the availability of HAART","volume":"46","author":"Kambugu","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2015.10.006_bib73","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/655785","article-title":"Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome","volume":"202","author":"Boulware","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2015.10.006_bib74","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1111\/j.1439-0507.2010.01870.x","article-title":"Immune reconstitution inflammatory syndrome (IRIS) associated with Cryptococcus neoformans infection in AIDS patients","volume":"54","author":"da Cunha Colombo","year":"2011","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.idc.2015.10.006_bib75","first-page":"185","article-title":"Intramedullary abscess resulting from disseminated cryptococcosis despite immune restoration in a patient with AIDS","volume":"44","author":"Rambeloarisoa","year":"2002","journal-title":"J\u00a0Infect"},{"issue":"5","key":"10.1016\/j.idc.2015.10.006_bib76","first-page":"e289","article-title":"Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature","volume":"51","author":"Skiest","year":"2005","journal-title":"J\u00a0Infect"},{"issue":"8","key":"10.1016\/j.idc.2015.10.006_bib77","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.tp.0000180530.17683.02","article-title":"Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome","volume":"80","author":"Singh","year":"2005","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.idc.2015.10.006_bib78","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20081463","article-title":"Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis","volume":"206","author":"Conti","year":"2009","journal-title":"J\u00a0Exp Med"},{"issue":"2","key":"10.1016\/j.idc.2015.10.006_bib79","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/cid\/cir276","article-title":"Opportunistic infection-associated immune reconstitution syndrome in transplant recipients","volume":"53","author":"Sun","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2015.10.006_bib80","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1111\/j.1600-6143.2007.01994.x","article-title":"Cellulitis revealing a cryptococcosis-related immune reconstitution inflammatory syndrome in a renal allograft recipient","volume":"7","author":"Lanternier","year":"2007","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.idc.2015.10.006_bib81","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/lt.21601","article-title":"Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient","volume":"14","author":"Crespo","year":"2008","journal-title":"Liver Transplant"},{"issue":"6","key":"10.1016\/j.idc.2015.10.006_bib82","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10096-008-0461-2","article-title":"Novel immune regulatory pathways and their role in immune reconstitution syndrome in organ transplant recipients with invasive mycoses","volume":"27","author":"Singh","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2015.10.006_bib83","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/cid\/ciu711","article-title":"Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression","volume":"60","author":"Sun","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib84","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1086\/503570","article-title":"The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy","volume":"42","author":"Ecevit","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2015.10.006_bib85","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1473-3099(10)70170-5","article-title":"Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions","volume":"10","author":"Haddow","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2015.10.006_bib86","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1468-1293.2008.00565.x","article-title":"Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis","volume":"9","author":"Tan","year":"2008","journal-title":"HIV Med"},{"issue":"5","key":"10.1016\/j.idc.2015.10.006_bib87","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/infdis\/jiv067","article-title":"Early ART after cryptococcal meningitis is associated with cerebrospinal fluid pleocytosis and macrophage activation in a multisite randomized trial","volume":"212","author":"Scriven","year":"2015","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2015.10.006_bib88","doi-asserted-by":"crossref","first-page":"e1004754","DOI":"10.1371\/journal.ppat.1004754","article-title":"Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis","volume":"11","author":"Jarvis","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.idc.2015.10.006_bib89","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/infdis\/jit388","article-title":"Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution syndrome","volume":"208","author":"Chang","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2015.10.006_bib90","first-page":"173","article-title":"Mediastinitis due to cryptococcal infection: a new clinical entity in the HAART era","volume":"45","author":"Trevenzoli","year":"2002","journal-title":"J\u00a0Infect"},{"issue":"6","key":"10.1016\/j.idc.2015.10.006_bib91","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/00365549850161223","article-title":"HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy","volume":"30","author":"Blanche","year":"1998","journal-title":"Scand J Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2015.10.006_bib92","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","volume":"8","author":"Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib93","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical Practice Guide lines for the Management of Cryptococcal Disease: 2010 update by the Infectious Disease Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2015.10.006_bib94","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/507895","article-title":"Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution","volume":"43","author":"Bicanic","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2015.10.006_bib95","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/604716","article-title":"Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients","volume":"49","author":"Bicanic","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.idc.2015.10.006_bib96","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","article-title":"Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"24","author":"Meintjes","year":"2010","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.idc.2015.10.006_bib97","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/313603","article-title":"Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups","volume":"30","author":"Graybill","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2015.10.006_bib98","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/j.ijid.2010.09.006","article-title":"Cryptococcal immune reconstitution syndrome during steroid withdrawal treated with hydroxychloroquine","volume":"15","author":"Narayanan","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2015.10.006_bib99","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1086\/649553","article-title":"Treatment of HIV-related inflammatory cerebral cryptococcoma with adalimumab","volume":"50","author":"Sitapati","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib100","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/ajt.13002","article-title":"Dramatic improvement of severe cryptococcosis-induced immune reconstitution syndrome with adalimumab in a renal transplant recipient","volume":"15","author":"Scemla","year":"2015","journal-title":"Am J Transplant"},{"issue":"16","key":"10.1016\/j.idc.2015.10.006_bib101","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1097\/QAD.0b013e328358daea","article-title":"Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS","volume":"26","author":"Brunel","year":"2012","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.idc.2015.10.006_bib102","first-page":"209","article-title":"Paradoxical immune reconstitution inflammatory syndrome associated with previous Cryptococcus neoformans infection in an HIV-positive patient requiring neurosurgical intervention","volume":"32","author":"Biagetti","year":"2009","journal-title":"New Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2015.10.006_bib103","doi-asserted-by":"crossref","first-page":"e5575","DOI":"10.1371\/journal.pone.0005575","article-title":"Early HAART reduces AIDS progression\/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial","volume":"4","author":"Zolopa","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.idc.2015.10.006_bib104","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/595006","article-title":"HIV\/AIDS: immune reconstitution inflammatory syndrome: a reappraisal","volume":"48","author":"French","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-80-2-176","article-title":"Prognostic factors in cryptococcal meningitis. A study in 111 cases","volume":"80","author":"Diamond","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2015.10.006_bib106","doi-asserted-by":"crossref","first-page":"471363","DOI":"10.1155\/2013\/471363","article-title":"New Insights into HIV\/AIDS-Associated Cryptococcosis","volume":"2013","author":"Antinori","year":"2013","journal-title":"ISRN AIDS"},{"key":"10.1016\/j.idc.2015.10.006_bib107","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1201-9712(01)90030-X","article-title":"Histopathology of cryptococcosis and other fungal infections in patients with acquired immunodeficiency syndrome","volume":"5","author":"Shibuya","year":"2001","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib108","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0022-510X(99)00047-7","article-title":"Rapid diagnosis of cryptococcal meningitis by microscopic examination of centrifuged cerebrospinal fluid sediment","volume":"164","author":"Sato","year":"1999","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.idc.2015.10.006_bib109","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000332544","article-title":"Cytologic diagnosis of Cryptococcus neoformans in HIV-positive patients","volume":"41","author":"Kanjanavirojkul","year":"1997","journal-title":"Acta Cytol"},{"key":"10.1016\/j.idc.2015.10.006_bib110","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1378\/chest.99.2.370","article-title":"Utility of bronchoscopic sampling techniques for cryptococcal disease in AIDS","volume":"99","author":"Malabonga","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.idc.2015.10.006_bib111","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/thx.48.1.75","article-title":"Diagnosis of pulmonary cryptococcosis by ultrasound guided percutaneous aspiration","volume":"48","author":"Lee","year":"1993","journal-title":"Thorax"},{"key":"10.1016\/j.idc.2015.10.006_bib112","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/JCM.32.7.1680-1684.1994","article-title":"Comparison of commercial kits for detection of cryptococcal antigen","volume":"32","author":"Tanner","year":"1994","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.idc.2015.10.006_bib113","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/JCM.18.5.1127-1130.1983","article-title":"Comparison of three commercial cryptococcal latex kits for detection of cryptococcal antigen","volume":"18","author":"Wu","year":"1983","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.idc.2015.10.006_bib114","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.1980.03310120047024","article-title":"False-negative cryptococcal antigen test","volume":"244","author":"Stamm","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2015.10.006_bib115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3181\/00379727-114-28586","article-title":"Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination","volume":"114","author":"Bloomfield","year":"1963","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.idc.2015.10.006_bib116","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/cid\/cir613","article-title":"Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma and urine from patients with HIV-associated cryptococcal meningitis","volume":"53","author":"Jarvis","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib117","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cid\/cir379","article-title":"Evaluation of a newly developed lateral flow immunoassay for the diagnosis of Cryptococcus","volume":"53","author":"Lindsley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib118","doi-asserted-by":"crossref","first-page":"e49451","DOI":"10.1371\/journal.pone.0049541","article-title":"Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory","volume":"7","author":"McMullan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2015.10.006_bib119","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1128\/CVI.00446-12","article-title":"Comparison of four assays for the detection of cryptococcal antigen","volume":"19","author":"Binnicker","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.idc.2015.10.006_bib120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/CVI.00536-12","article-title":"Large-scale evaluation of the Immuno-Mycologics lateral flow and Enzyme-Linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid","volume":"20","author":"Hansen","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.idc.2015.10.006_bib121","doi-asserted-by":"crossref","first-page":"e0127117","DOI":"10.1371\/journal.pone.0127117","article-title":"Evaluation of a new cryptococcal antigen lateral flow immunoassay in serum, cerebrospinal fluid and urine for the diagnosis of cryptococcosis: a meta-analysis and systematic review","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.idc.2015.10.006_bib122","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/cid\/cit641","article-title":"Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal lateral flow assay on cerebrospinal fluid","volume":"58","author":"Kabanda","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2015.10.006_bib123","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/cid\/civ263","article-title":"Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study","volume":"61","author":"Williams","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib124","doi-asserted-by":"crossref","first-page":"e69288","DOI":"10.1371\/journal.pone.0069288","article-title":"Cost effectiveness of cryptococcal antigen screening as a strategy to prevent cryptococcal meningitis in South Africa","volume":"8","author":"Jarvis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2015.10.006_bib125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7326\/0003-4819-69-1-45","article-title":"Serology of human cryptococcosis","volume":"69","author":"Bindschadler","year":"1968","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.idc.2015.10.006_bib126","first-page":"3","article-title":"Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group","volume":"326","author":"Saag","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2015.10.006_bib127","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/clinids\/18.5.789","article-title":"Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis","volume":"18","author":"Powderly","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2015.10.006_bib128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"Bicanic","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2015.10.006_bib129","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients With HIV-associated cryptococcal meningitis: implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.fgb.2014.10.003","article-title":"Cryptococcosis diagnosis and treatment: what do we know now","volume":"78","author":"Perfect","year":"2015","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.idc.2015.10.006_bib131","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00002030-199712000-00010","article-title":"Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis","volume":"11","author":"Leenders","year":"1997","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.idc.2015.10.006_bib132","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/653606","article-title":"Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety","volume":"51","author":"Hamill","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib133","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group","volume":"337","author":"van der Horst","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2015.10.006_bib134","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJM198708063170602","article-title":"Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks","volume":"317","author":"Dismukes","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2015.10.006_bib135","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2015.10.006_bib136","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"Brouwer","year":"2004","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.idc.2015.10.006_bib137","doi-asserted-by":"crossref","first-page":"e2870","DOI":"10.1371\/journal.pone.0002870","article-title":"Major role for amphotericin-flucytosine combination in severe cryptococcosis","volume":"3","author":"Dromer","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2015.10.006_bib138","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/infdis\/jit164","article-title":"Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients","volume":"208","author":"O\u2019Connor","year":"2013","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2015.10.006_bib139","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1128\/AAC.01800-12","article-title":"Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis","volume":"57","author":"Bratton","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2015.10.006_bib140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1086\/515074","article-title":"Early mycological treatment failure in AIDS-associated cryptococcal meningitis","volume":"28","author":"Robinson","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib141","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","article-title":"Determinants of disease presentation and outcome during cryptococcosis: The Crypto A\/D Study","volume":"4","author":"Dromer","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.idc.2015.10.006_bib142","series-title":"Antimicrobial therapy and vaccines","first-page":"656","article-title":"Flucytosine","author":"Drew","year":"1997"},{"key":"10.1016\/j.idc.2015.10.006_bib143","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1086\/599112","article-title":"A\u00a0phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib144","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cir745","article-title":"Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis","volume":"54","author":"Loyse","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2015.10.006_bib145","doi-asserted-by":"crossref","first-page":"ofu070","DOI":"10.1093\/ofid\/ofu070","article-title":"Standardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings","volume":"1","author":"Bahr","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib146","first-page":"76","article-title":"Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis","volume":"64","author":"Muzoora","year":"2012","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.idc.2015.10.006_bib147","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/QAD.0b013e328354b419","article-title":"A\u00a0phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole with short-course amphotericin B for cryptococcal meningitis","volume":"26","author":"Jackson","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.idc.2015.10.006_bib148","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi","volume":"50","author":"Nussbaum","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib149","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM199102283240902","article-title":"A\u00a0placebo-controlled trial of maintenance therapy with fluconazole after treatment for cryptococcal meningitis in the Acquired Immunodeficiency Syndrome","volume":"324","author":"Bozette","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2015.10.006_bib150","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/374849","article-title":"Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with HAART: a prospective, multicenter, randomized study","volume":"36","author":"Vibhagool","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib151","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/381261","article-title":"Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with HAART: an international observational study","volume":"38","author":"Mussini","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib152","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1001\/archinte.1989.00390100107024","article-title":"Itraconazole therapy for cryptococcal meningitis and cryptococcosis","volume":"149","author":"Denning","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idc.2015.10.006_bib153","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/515110","article-title":"A\u00a0comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"28","author":"Saag","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2015.10.006_bib154","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging or refractory fungal infections","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib155","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dki288","article-title":"Activity of posaconazole in the treatment of central nervous system fungal infections","volume":"56","author":"Pitisuttithum","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.idc.2015.10.006_bib156","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/cid\/cit019","article-title":"Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis","volume":"56","author":"Bisson","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2015.10.006_bib157","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009012.pub2","article-title":"Optimal timing for HAART initiation in patients with HIV infection and concurrent cryptococcal meningitis","author":"Njei","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.idc.2015.10.006_bib158","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1086\/652652","article-title":"Early versus delayed initiation of HAART for concurrent HIV infection and cryptococcal meningitis in sub-Saharan Africa","volume":"50","author":"Makadzange","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"16","key":"10.1016\/j.idc.2015.10.006_bib159","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJMoa1014181","article-title":"Integration of antiretroviral therapy with tuberculosis treatment","volume":"365","author":"Abdool Karim","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.idc.2015.10.006_bib160","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","article-title":"Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis","volume":"365","author":"Blanc","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2015.10.006_bib161","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after cryptococcal meningitis","volume":"370","author":"Boulware","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2015.10.006_bib162","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/01.tp.0000173774.74388.49","article-title":"Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection","volume":"80","author":"Singh","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.idc.2015.10.006_bib163","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/430606","article-title":"An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients","volume":"40","author":"Singh","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2015.10.006_bib164","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A\u00a0comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis","volume":"301","author":"Bennett","year":"1970","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2015.10.006_bib165","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0002-9343(91)90126-I","article-title":"Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome","volume":"91","author":"Denning","year":"1991","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.idc.2015.10.006_bib166","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/cid\/ciu596","article-title":"The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis","volume":"59","author":"Rolfes","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib167","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1086\/342299","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis","volume":"35","author":"Newton","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib168","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1086\/515161","article-title":"Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting","volume":"28","author":"Park","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib169","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/infdis\/168.2.508","article-title":"Correlation of in\u00a0vitro azole susceptibility testing with in\u00a0vivo response in a murine model of cryptococcal meningitis","volume":"168","author":"Velez","year":"1993","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib170","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1128\/AAC.44.6.1544-1548.2000","article-title":"Correlation of fluconazole MICs with clinical outcome in cryptococcal infection","volume":"44","author":"Aller","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2015.10.006_bib171","doi-asserted-by":"crossref","first-page":"e88875","DOI":"10.1371\/journal.pone.0088875","article-title":"Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest","volume":"9","author":"Smith","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2015.10.006_bib172","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00002030-199202000-00008","article-title":"Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients","volume":"6","author":"Nightingale","year":"1992","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.idc.2015.10.006_bib173","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1468-1293.2004.00201.x","article-title":"A\u00a0multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency","volume":"5","author":"Chetchotisakd","year":"2004","journal-title":"HIV Med"},{"issue":"3","key":"10.1016\/j.idc.2015.10.006_bib174","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004773.pub2","article-title":"Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV","author":"Chang","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idc.2015.10.006_bib175","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","article-title":"Cryptococcal infection in a cohort of HIV-1 infected Ugandan adults","volume":"16","author":"French","year":"2002","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.idc.2015.10.006_bib176","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/cid\/ciu937","article-title":"Prevalence, correlates and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012","volume":"60","author":"McKenney","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib177","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/597262","article-title":"Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa","volume":"48","author":"Jarvis","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2015.10.006_bib178","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count of < 100 cells\/\u03bcL who start HIV therapy in resource-limited settings","volume":"51","author":"Meya","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib179","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1097\/QAI.0000000000000484","article-title":"Cryptococcal antigen screening and early antifungal treatment to prevent cryptococcal meningitis: a review of the literature","volume":"68","author":"Kaplan","year":"2015","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.idc.2015.10.006_bib180","doi-asserted-by":"crossref","first-page":"e62213","DOI":"10.1371\/journal.pone.0062213","article-title":"Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program \u2013 Vietnam","volume":"8","author":"Smith","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2015.10.006_bib181","series-title":"Rapid advice: diagnosis, prevention and management of Cryptococcal disease in HIV-infected adults, adolescents and children","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.idc.2015.10.006_bib182","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/cid\/cis725","article-title":"Reconsidering cryptococcal antigen screening in the US among persons with CD4 < 100 cells\/mcl","volume":"55","author":"Rajasinham","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib183","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/592690","article-title":"Cryptococcosis in solid organ transplant recipients: current state of the science","volume":"47","author":"Singh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2015.10.006_bib184","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1128\/IAI.59.10.3700-3707.1991","article-title":"Cryptococcus neoformans serotype A glucuronoxylomannan protein conjugate vaccines: synthesis, characterization, and immunogenicity","volume":"59","author":"Devi","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.idc.2015.10.006_bib185","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1128\/AAC.38.3.580","article-title":"Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B","volume":"38","author":"Mukherjee","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2015.10.006_bib186","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.00274-06","article-title":"Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain","volume":"75","author":"Wormley","year":"2007","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.idc.2015.10.006_bib187","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","article-title":"Adjunctive interferon-\u03b3 immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial","volume":"26","author":"Jarvis","year":"2012","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.idc.2015.10.006_bib188","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","article-title":"Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis","volume":"1889","author":"Pappas","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2015.10.006_bib189","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(11)60839-2","article-title":"Fungal infections complicating tumor necrosis factor\u03b1 blockade therapy","volume":"83","author":"Isiodras","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.idc.2015.10.006_bib190","doi-asserted-by":"crossref","first-page":"e0119090","DOI":"10.1371\/journal.pone.0119090","article-title":"Risk factors for invasive Cryptococcus neoformans diseases: a case-control study","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.idc.2015.10.006_bib191","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(07)70085-3","article-title":"Immune reconstitution syndrome associated with opportunistic mycoses","volume":"7","author":"Singh","year":"2007","journal-title":"Lancet Infect Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552015000951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552015000951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T12:23:09Z","timestamp":1748780589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552015000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":191,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0891552015000951"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2015.10.006","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryptococcosis","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2015.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}